Showing results (81-90 of 1,586) with videos related to
Sort By:
Pageof 159
Antiviral Therapy|March 7, 2002
Ritonavir/saquinavir plus one nucleoside reverse transcriptase inhibitor (NRTI) versus indinavir plus two NRTIs in protease inhibitor-naive HIV-1-infected adults (IRIS study)E Florence, C Dreezen, P Desmet, et al.European Journal of Clinical Microbiology|June 1, 1985
Analysis of the interferon system in African patients with acquired immunodeficiency syndromeK Huygen, F Mascart-Lemone, S Cran, et al.Antimicrobial Agents and Chemotherapy|December 12, 2007
Hepatotoxicity observed in clinical trials of aplaviroc (GW873140)W G Nichols, H M Steel, T Bonny, et al.AIDS (London, England)|May 1, 1997
A dose comparison study of a new triazole antifungal (D0870) in HIV-positive patients with oral candidiasisS De Wit, B Dupont, J D Cartledge, et al.HIV Medicine|April 19, 2003
TRIZAL study: switching from successful HAART to Trizivir (abacavir-lamivudine-zidovudine combination tablet): 48 weeks efficacy, safety and adherence resultsC Katlama, S Fenske, B Gazzard, et al.Science (New York, N.Y.)|March 22, 1985
Bovine leukemia virus-related antigens in lymphocyte cultures infected with AIDS-associated virusesL Thiry, S Sprecher-Goldberger, P Jacquemin, et al.JAMA|November 8, 1985
Seroepidemiological studies of HTLV-III antibody prevalence among selected groups of heterosexual AfricansN Clumeck, M Robert-Guroff, P Van de Perre, et al.Antimicrobial Agents and Chemotherapy|April 4, 1998
Effect of fluconazole on indinavir pharmacokinetics in human immunodeficiency virus-infected patientsS De Wit, M Debier, M De Smet, et al.Antimicrobial Agents and Chemotherapy|December 1, 1992
Pharmacokinetics of R 82913 in AIDS patients: a phase I dose-finding study of oral administration compared with intravenous infusionS De Wit, P Hermans, B Sommereijns, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 4, 2018
Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free casesM C Payen, I Muylle, O Vandenberg, et al.Pageof 159